Page 2 - Quotient Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quotient science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quotient Science Today - Breaking & Trending Today

Nanoform's final clinical results confirm value proposition to the pharma industry

Nanoform's final clinical results confirm value proposition to the pharma industry
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , United Kingdom , Christian Jones , Chris Roe , Edward Haeggstr , Danske Bank , Senior Research Fellow At Quotient Sciences , Finnish Financial Supervisory Authority , Nanoform Finland Plc , Finland Branch , Drug Development , Area Under , Quotient Science , Senior Research Fellow , Quotient Sciences , Overcoming Drug Development Challenges , Nasdaq First North Growth Market , Certified Adviser , ஒன்றுபட்டது கிஂக்டம் , கிறிஸ்துவர் ஜோன்ஸ் , கிறிஸ் ரோ , பின்னிஷ் நிதி மேற்பார்வை அதிகாரம் , பின்லாந்து கிளை , மருந்து வளர்ச்சி , பரப்பளவு கீழ் , மேற்கோள் அறிவியல் ,

Nanoform 1-12/2020 report and new company near-term target introduced

Nanoform 1-12/2020 report and new company near-term target introduced
Nanoform
Company Announcement
Nanoform 1-12/2020 report and new company near-term target introduced
First GMP manufacturing campaign and first dosing in humans successfully completed, positive interim results from first clinical study announced, all near-term business targets set out in IPO achieved, ten new Small Molecule PoC projects started, four more non-GMP lines commissioned, first Biologics PoC project commenced and a new near-term business target introduced: “At least 3 new non-GMP lines in 2021 and 2 new GMP lines in 2022”.
10-12/2020 key financials:
- Revenue was EUR 186 thousand (EUR 49 thousand in 10-12/2019).
- The gross profit and margin came in at EUR 135 thousand and 73%, during 10-12/2019 the gross profit was negative. ....

Eteläuomen Läi , United States , United Kingdom , April Nanoform , Johanna Tuomisto , Eric Peter , Miguel Calado , July Nanoform , Biologics Po , Sergie Letser , Christian Jones , Cynthia Schwalm , June Nanoform , Finnish Financial Supervisory Authority , Finnish Medicines Agency , Finland Branch , Orion Corporation , Nanoform United States Inc , Danske Bank , Coast Us Biotech Company , Nanoform Finland Plc , Herantis Pharma Plc , Company Announcement , Small Molecule Poc , Biologics Poc , January Nanoform United States ,

Additional Positive Interim Results From Nanoform's Clinical Study

Additional Positive Interim Results From Nanoform's Clinical Study
pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , United Kingdom , Nanoform Finland Plc , Quotient Science , ஒன்றுபட்டது கிஂக்டம் , மேற்கோள் அறிவியல் ,

Additional Positive Interim Results from Nanoform's Clinical Study

Additional Positive Interim Results from Nanoform s Clinical Study
USA - English
Share this article
Share this article
HELSINKI, Feb. 24, 2021 /PRNewswire/ Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study. The fast absorption data implies that small is powerful
® and might offer viable alternatives to complex formulation approaches such as cyclodextrin based technologies.
Nanoform has received the second interim pharmacokinetic (PK) study results related to its Phase 1, single-centre, part crossover, open-label, partially-randomised study designed to evaluate the PK profile of piroxicam following administration of nanoformed oral immediate release (IR) piroxicam tablet and IR reference products in healthy subjects (UNICORN). ....

Eteläuomen Läi , United Kingdom , Danske Bank , Prnewswire Nanoform Finland Plc , Finnish Financial Supervisory Authority , Finland Branch , Finland Plc , Quotient Science , Nasdaq First North Growth Market , Certified Adviser , ஒன்றுபட்டது கிஂக்டம் , பின்னிஷ் நிதி மேற்பார்வை அதிகாரம் , பின்லாந்து கிளை , பின்லாந்து ப்ல் , மேற்கோள் அறிவியல் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,

Additional Positive Interim Results from Nanoform's Clinical Study

Additional Positive Interim Results from Nanoform's Clinical Study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , United Kingdom , Danske Bank , Prnewswire Nanoform Finland Plc , Finnish Financial Supervisory Authority , Finland Branch , Finland Plc , Quotient Science , Nasdaq First North Growth Market , Certified Adviser , ஒன்றுபட்டது கிஂக்டம் , பின்னிஷ் நிதி மேற்பார்வை அதிகாரம் , பின்லாந்து கிளை , பின்லாந்து ப்ல் , மேற்கோள் அறிவியல் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,